Login / Signup

Description of BCG and Tuberculosis Disease in a Cohort of 79 Patients with Chronic Granulomatous Disease.

Ximena León-LaraUriel Pérez-BlancoMarco A Yamazaki-NakashimadaJuan Carlos Bustamante-OgandoNancy Aguilar-GómezHernán Cristerna-TarrasaAidé-Tamara Staines-BooneOmar J Saucedo-RamírezEunice Fregoso-ZuñigaAna-Paola Macías-RoblesMaría R Canseco-RaymundoMarco Antonio Venancio HernándezCristina Moctezuma-TrejoBerenise Gámez-GonzálezCarmen Zarate-HernándezRoselia Ramírez-RiveraSelma Scheffler-MendozaNancy Jiménez-PolvoLeticia Hernández-NietoJocelyn Carmona-VargasMaría L García-CruzÓscar Zavaleta-MartínezCarla Marina Roman-MontesVictoria Cervantes-ParraAnelena González-ReynosoRogelio Guzmán-CotayaFrancisco Espinosa-RosalesPatricia Saltigeral-SimentalSara Espinosa-PadillaLizbeth Blancas-Galicia
Published in: Journal of clinical immunology (2024)
This report highlights the importance of considering TB in endemic areas and BCG complications in children with CGD to enable appropriate diagnostic and therapeutic approaches to improve prognosis and reduce the risk of relapse.
Keyphrases
  • mycobacterium tuberculosis
  • risk factors
  • hiv aids
  • rheumatoid arthritis
  • pulmonary tuberculosis
  • adverse drug
  • hiv infected
  • antiretroviral therapy